Futura Medical plc - FUM

Futura Medical plc develops products for the prescription and consumer healthcare markets focusing on sexual healthcare and pain relief management. The company offers CSD500, a condom that incorporates an erectogenic gel to help men maintain a firmer erection during intercourse whilst wearing a condom. It is also developing MED2002, a topical gel applied directly to the penis for the treatment of male erectile dysfunction that is in Final Phase III program. In addition, the company develops pain relief products, including TPR100, a topical diclofenac pain relief gel; TIB200, a topical ibuprofen pain relief gel; and SPR300, a topical methyl salicylate pain relief gel. It operates in the Middle East/ROW, the United States, and Europe. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.